Mass General Cancer Center Grand Rounds
Grand Rounds
Mass General Cancer Center Grand Rounds is a CME accredited weekly seminar series. Cutting edge topics, case studies and conference highlights will be presented.
Fall 2022 - Spring 2023 Grand Rounds
Time: Thursdays, 12:00 PM–1:00 PM
Location: Simches 3110
Intended Audience: Internal MGH Faculty and Staff
Course Director: Colin D. Weekes, MD, PhD
The Mass General Cancer Center Grand Rounds program has emerged as a premiere oncology conference in Boston. This program provides an opportunity for Mass General professional staff and fellows to learn from national and international leaders and innovators in cancer treatment and research. This year’s theme for the series is Immunotherapy.
Grand Rounds offers CME credit, and is structured as a 45-minute lecture followed by 15 minutes of discussion and interaction. Please see below to view the weekly topics and presenters.
Fall 2022 Grand Rounds Schedule
September 15, 2022
Leveraging Opportunities to Facilitate Inclusive Cancer Drug Development
Lola Fashoyin-Aje, MD, MPH
Deputy Division Director
Associate Director, Science & Policy to Address Disparities
Oncology Center of Excellence
FDA
September 22, 2022
ACS-IRG Scholar Presentations
The MGH Catch Project: Improving Community Access to Colon Cancer Screening
Adjoa Anyane-Yeboa, MD, MPH
Massachusetts General Hospital
An Omics Approach to Drug Discovery
Liron Bar-Peled, PhD
Massachusetts General Hospital Cancer Center
CAR Talk: What Clinicians Say and Patients Understand about Chimeric Antigen Receptor T-cell (CAR-T) Therapy
Tejaswini Dhawale, MD
Massachusetts General Hospital Cancer Center
Spatial Transcriptomics of HCC Reveals Distinct Vascular Neighborhoods
Joseph Franses, MD, PhD
Massachusetts General Hospital Cancer Center
Intermediate States in Pancreatic Cancer Tumorigenesis Inferred by Single-Nucleus RNA-Sequencing
William Hwang, MD, PhD
Massachusetts General Hospital
September 29, 2022
Lymphocytes as a “Living Drug” for the Treatment of Cancer
Steven A. Rosenberg, MD, PhD
Chief, Surgery Branch
National Cancer Institute
October 6, 2022
Extending Immunotherapy Combinations in Gastroesophageal Cancer: How, What and When?
Ian Chau, MD, FRCP
Department of Medicine
Royal Marsden Hospital
October 13, 2022
New Considerations for Immunotherapy in Sarcoma
Seth M. Pollack, MD
Director of the Sarcoma Program, Lurie Cancer Center
Steven T. Rosen Professor of Cancer Biology
Associate Professor, Department of Medicine (Hematology and Oncology)
Northwestern University Feinberg School of Medicine
October 27, 2022
Kidney Cancer: Bench to Bedside and Back
James Brugarolas, MD, PhD
Director, Kidney Cancer Program
UT Southwestern
November 3, 2022
Debate: Adjuvant/Neoadjuvant Immune Checkpoint Inhibitor Therapy
Rodabe Amaria, MD
Associate Professor, Department of Melanoma Medical Oncology
Director of Melanoma Clinical Research and Early Drug Development
The University of Texas MD Anderson Cancer Center
Jeffrey Weber, MD, PhD
Deputy Director
Laura and Isaac Perlmutter Cancer Center
Professor of Medicine
NYU School of Medicine
Paul Chapman, MD
Attending Physician
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Medical College and Graduate School of Medical Sciences of Cornell University
November 10, 2022
TLR9 Agonists in Melanoma and Other Cancers: Current Development, Next Steps
Diwakar Davar, MD
Assistant Professor of Medicine
Medical Oncologist/Hematologist
UPMC
November 17, 2022
Lippard Lecture: Heterogeneity of Breast Cancer Across Diverse Populations
Olufunmilayo Olopade, MD, FACP
Walter L. Palmer Distinguished Service Professor of Medicine
Professor of Human Genetics
Director, Center for Clinical Cancer Genetics and Global Health
UChicago Medicine
December 1, 2022
The Chabner Pioneers in Oncology Lectureship: Translating Aging Biology Into Patient Care
Norman Sharpless, MD
Former Director, NCI
December 15, 2022
Title TBD
Arlene Sharpe, MD, PhD
George Fabyan Professor of Comparative Pathology
Chair, Department of Immunology
Co-Director, Evergrande Center for Immunologic Diseases
Harvard Medical School
Stephen Elledge, PhD
Gregor Mendel Professor of Genetics
Department of Genetics, Harvard Medical School
Division of Genetics, Brigham & Women’s Hospital
Spring 2023 Grand Rounds Schedule
Please check back soon for the Spring 2023 schedule.
Previous Grand Rounds
Spring 2022
January 6, 2022
ASH Update
Rupa Narayan, MD
Massachusetts General Hospital Cancer Center
Connor Johnson, MD
Massachusetts General Hospital Cancer Center
Anem Waheed, MD
Massachusetts General Hospital Cancer Center
Matt Frigault, MD
Massachusetts General Hospital Cancer Center
Andrew Yee, MD
Massachusetts General Hospital Cancer Center
January 13, 2022
Junior Scientist Lecture
Looking Beyond the Marker: Pharmacologic and Immunotherapeutic Targeting of MUC16 (CA-125) Positive Gynecologic Cancers
Oladapo Yeku, MD
Massachusetts General Hospital Cancer Center
Epidemiology and Prognostic Implications of Cutaneous Immunotherapy Toxicities
Eugene Semenov, MD
Massachusetts General Hospital
January 20, 2022
Confronting Inequity in Modern Therapy for Rare Melanomas
Alexander Shoushtari, MD
Memorial Sloan Kettering Cancer Center
January 27, 2022
Advancing Therapies for Children and Adults with Rare Solid Tumors or Genetic Tumor Predisposition Syndromes
Brigitte Widemann, MD
National Institutes of Health
February 3, 2022
2021 Assembly Award Winners and Lectureship
Safety and Immunogenicity of SARS-CoV2 Vaccines in Patients with Cancer
Justin Gainor, MD
Massachusetts General Hospital Cancer Center
Clinical Resistance to KRAS Inhibition
Ryan Corcoran, MD, PhD
Massachusetts General Hospital Cancer Center
February 10, 2022
Turning on Apoptotic Switch in Leukemia: BCL-2 and Beyond
Amir Fathi, MD
Massachusetts General Hospital Cancer Center
Marina Konopleva, MD
MD Anderson Cancer Center
February 17, 2022
Clinical Pathologic Conference: A 66-Year-Old Man with Progressive Dyspnea and Neck Swelling, and a Lung Mass
Jennifer Temel MD – Medical Oncology
Katie Keane, MD - Radiation Oncology
David Dudzinski, MD - Cardiology
Subba Digumarthy, MD - Radiology
Colleen Keyes, MD - Pulmonary
Daniel Shepherd, MD - Pathology
Massachusetts General Hospital
March 3, 2022
Leadership Toolbox for Faculty Development Strategies to Enhance Diversity within the Profession
Charles Thomas, Jr., MD
Dartmouth-Hitchcock Norris Cotton Cancer Center
March 10, 2022
Engineering CAR-T Cells: Combating Tumor Resistance and Relapse
Renier Brentjens, MD, PhD
Roswell Park Comprehensive Cancer Center
March 17, 2022
Informing Race/Ethnicity Modeling for Colorectal Cancer Screening
John Carethers, MD
University of Michigan
March 24, 2022
The Race Between Immunity and Ovarian Cancer: How Tryptophan Metabolism Shapes the Outcome
Adekunle Odunsi, MD, PhD
University of Chicago
March 31, 2022
Senior Fellows Lecture
Interrogating the Immunogenicity of SARS-CoV-2 Vaccines in Chronic Lymphocytic Leukemia
Erika Haydu, MD, PhD
Fellow in Hematology/Oncology
Mass General Cancer Center / Dana-Farber Cancer Institute
Improving Outcomes for Hospitalized Patients with Advanced Cancer
Daniel Lage, MD, MSc
Fellow in Hematology/Oncology
Mass General Cancer Center / Dana-Farber Cancer Institute
Decoding the Rules of Pancreatic Cancer Plasticity and Immune Regulations
Arnav Mehta, MD, PhD
Fellow in Hematology/Oncology
Mass General Cancer Center / Dana-Farber Cancer Institute
April 14, 2022
Personalizing Care for Older Adults with Cancer
Heidi Klepin, MD
Wake Forest School of Medicine
Lisa Newman, MD, MPH
Weill Cornell Medicine
April 28, 2022
The Business of Cell Therapies for Cancer
James Economou, MD, PhD
University of California Los Angeles
Raymond Osarogiagbon, MD
Baptist Cancer Center
May 12, 2022
ACS IRG Scholars
Raj Gopal, MD, PhD
Massachusetts General Hospital
Daniel Hall, PhD
Massachusetts General Hospital
Andrew Liss, PhD
Massachusetts General Hospital
Erica Shenoy, MD, PhD
Massachusetts General Hospital
Eric Wehrenberg-Klee, MD
Massachusetts General Hospital
May 19, 2022
Clinical Pathologic Conference: A 22-Year-Old Female with Abdominal Pain
Baris Boyraz, MD, PhD
Massachusetts General Hospital
Sophia Kamran, MD
Massachusetts General Hospital
Allison Kimball, MD
Massachusetts General Hospital
Philip Saylor, MD
Massachusetts General Hospital Cancer Center
Madeleine Sertic, MBBCH, BAO
Massachusetts General Hospital
Fall 2021
September 23, 2021
Industry Roundtable: A Conversation About Cancer Equity
Ruma Bhagat, MPH
Senior Science Leader Global Health Equity Strategy
Genentech, Inc.
Patrice Matchaba, MD
Global Head of Corporate Responsibility
Novartis US
Coleman Obasaju, MD, PhD
Senior Medical Director - Oncology
Eli Lilly and Company
David Windsor
Clinical Trials Diversity Ops Lead for Oncology
Pfizer
September 30, 2021
Keynote Address: The Impact of Population and Tumor Heterogeneity in Cancer Genome Science
John D. Carpten, PhD
Professor and Chair of Translational Genomics
Director, Institute of Translational Genomics
Royce and Mary Trotter Chair in Cancer Research
Department of Translational Genomics
Keck School of Medicine of USC
October 7, 2021
DNA Damage Repair Deficient Pancreas Cancer
Talia Golan, MD
Head of Sheba Pancreatic Cancer Center
Sheba Medical Center, Tel HaShomer
October 14, 2021
Clinical Pathologic Conference: A 29-Year-Old Woman with Jaundice and Chronic Diarrhea
Jon Dubois, MD
Medical Oncologist
Massachusetts General Hospital Cancer Center
Jennifer Wo, MD
Radiation Oncology
Massachusetts General Hospital
Avinash Kambadakone, MD
Radiology
Massachusetts General Hospital
M. Lisa Zhang, MD
Pathology
Massachusetts General Hospital
October 21, 2021
Utilizing Underlying Tumor Biology to Guide Immunotherapy Drug Development in Sarcoma, One Subtype at a Time
Sandra D’Angelo, MD
Associate Attending Physician
Memorial Sloan Kettering Cancer Center
October 28, 2021
Patient-Centered Care in the Precision Oncology Era
Laura Petrillo, MD
Palliative Medicine
Mass General Cancer Center
November 4, 2021
The Chabner Pioneers in Oncology Lectureship: Getting to the Root of Cancer Health Disparities: A Journey to Health Equity
Michele K. Evans, MD
Deputy Scientific Director & Chief
Health Disparities Research Section
National Institute on Aging
National Institutes of Health
November 11, 2021
Immune-Related Toxicities: Diversity in Clinical Research and Innovation
Jarushka Naidoo, MB, BCH, MHS
Assistant Professor of Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Bloomberg-Kimmel Institute for Cancer Immunotherapy
November 18, 2021
Lippard Lecture: Endometrial Cancer: Genetic Models & Translational Studies
Diego Castrillon, MD, PhD
Professor
Vernie A. Stembridge, MD, Distinguished Chair in Pathology
UT Southwestern Medical Center
December 2, 2021
Hot Topic Debate: Is Disease-Free Survival an Acceptable Surrogate Endpoint for Emerging Adjuvant TKI/IO Studies in NSCLC?
Justin Gainor, MD
Associate Professor of Medicine
Harvard Medical School
Massachusetts General Hospital
Rebecca Heist, MD, MPH
Associate Professor of Medicine
Harvard Medical School
Massachusetts General Hospital
Zofia Piotrowska, MD
Assistant Professor, Medicine
Harvard Medical School
Assistant in Medicine, Medicine
Massachusetts General Hospital
December 9, 2021
Disrupting the Paradigm in Cancer Research: Bringing the Patient into the P-Value
Jill Feldman
Group Founder, EGFR Resisters
Spring 2021
January 7, 2021
ASH Update
Sharl Azar, MD
Jeffrey Barnes, MD, PhD
Andrew Brunner, MD
Thomas Spitzer, MD
Andrew Yee, MD
Massachusetts General Hospital Cancer Center
January 14, 2021
Cancer Therapeutics and Diagnostics: A View from My Lens
David Schenkein, MD
General Partner, Google Ventures
Adjunct Professor of Medicine, Hematology and Oncology
Tufts Medical Center
January 21, 2021
Unraveling Immune Checkpoint Inhibitor Toxicities
Douglas B. Johnson, MD, MCSI
Assistant Professor of Medicine, Clinical Director, Melanoma
Vanderbilt- Ingram Cancer Center
Vanderbilt University
January 28, 2021
A Functional Genomics Platform for Precision Medicine
Jeffrey W. Tyner, PhD
Professor of Medicine
Department of Cell, Development and Cancer Biology
Oregon Health and Sciences University
February 4, 2021
MGH American Cancer Society Institutional Research Grant (IRG) Awardee Presentations
Deborah Forst, MD
Massachusetts General Hospital Cancer Center
Rachel Jimenez, MD
Massachusetts General Hospital
Christine Chiasson MacKenzie, PhD
Massachusetts General Hospital Cancer Center
February 11, 2021
Refining Disease States in Response to PD-1 Blockade
Matthew D. Hellman, MD
Lung Cancer, Immunotherapy, Clinical Trials
Associate Attending, Hematology/Oncology
Weill Cornell Medical College
Memorial Sloan Kettering Cancer Center
February 18, 2021
CPC: A 49-Year-Old Man with Relapsed Acute Myeloid Leukemia
Richard Newcomb, MD
Dana-Farber Cancer Institute
Andrew Crabbe, MD, PhD
Massachusetts General Hospital
Andrew Brunner, MD
Massachusetts General Hospital Cancer Center
Yi-Bin Chen, MD
Massachusetts General Hospital Cancer Center
March 4, 2021
New Findings in Endocrine Therapy of Breast Cancer
Nancy Davidson, MD
Senior Vice President, Director and Professor
Clinical Research Division, Fred Hutch
Raisbeck Endowed Chair for Collaborative Research
Fred Hutch
President and Executive Director, Seattle Cancer Care Alliance
March 11, 2021
Understanding Responses to Cancer Therapy: The Tissue is the Issue, the Scoop is in the Poop, and You are What You Eat
Jennifer Wargo, MD
MD Anderson Cancer Center
March 18, 2021
Molecular Profiling of Gliomas: Secrets Revealed
Arnab Chakravarti, MD
Chair and Professor, Department of Radiation Oncology
Klotz Family Chair of Cancer Research
Director, Brain Tumor Program
Ohio State University Comprehensive Cancer Center and Richard L. Solove Research Institute
Arthur G. James Cancer Hospital
The Ohio State University Medical School
March 25, 2021
Late Recurrences in Estrogen Receptor Breast Cancer
Stuart B. Padnos Professor of Breast Cancer Research
University of Michigan Rogel Cancer Center
April 1, 2021
Debate: Discussion of Incorporation of Radiation Therapy into Management of Localized Pancreas Adenocarcinoma
Ted Hong, MD
Director, Gastrointestinal Service, Department of Radiation Oncology
Associate Clinical Director, Department of Radiation Oncology
Massachusetts General Hospital
Wells Messersmith, MD
Professor, Medicine-Medical Oncology
University of Colorado Anschutz Medical Campus
April 8, 2021
Immunotherapy of Small Cell Lung Cancer: What is Next?
Taofeek Owonikoko, MD, PhD
Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine
April 15, 2021
Junior Faculty Lecture: Regulatory Drivers in Cancers
Esther Rheinbay, PhD
Assistant Professor of Medicine
Massachusetts General Hospital Cancer Center
Liron Bar-Peled, PhD
Assistant Professor, Medicine
Harvard Medical School
Investigator, Center for Cancer Research
Massachusetts General Hospital
April 22, 2021
Looking Beyond Scopes, Scans, and Smears: The Future of Cancer Screening
Sana Raoof, MD, PhD
Medical Resident
Massachusetts General Hospital
April 29, 2021
Development of Epigenetic Therapy in GI Malignancies
Nita Ahuja, MD, MBA, FACS
William H. Carmalt Professor of Surgery
Chair, Department of Surgery
Interim Director, Yale Cancer Center
Interim Physician-in-Chief, Smilow Cancer Hospital
Nilo Azad, MD
Associate Professor of Oncology
Johns Hopkins University
May 6, 2021
State of Cancer in America: 2021
Clifford A. Hudis, MD
CEO, American Society of Clinical Oncology
May 13, 2021
Next Gen Immunotherapy Strategies in Prostate Cancer: Can Immunocytokines Succeed Where PD1/PDL1 Inhibitors Have Not?
Ravi A. Madan, MD
Clinical Director, Genitourinary Malignancies Branch
National Institutes of Health
May 20, 2021
CPC: A 25-Year-Old Man with Visual Changes, Thrombocytopenia, and B Cell-ALL
Zack DeFilipp, MD
Dept. of Medicine, MGH
Annabelle Anandappa, MD
Dept. of Medicine, MGH
Karen Rodriguez, MD
Dept. of Radiology, MGH
Judith Ferry, MD
Dept. of Pathology, MGH
May 27, 2021
Oncolytic Immunovirotherapy against Glioma: From the Bench to the Clinic and Back
Evanthia Galanis, MD
Medical Oncologist, Brain Tumor Program
Mayo Clinic
Fall 2020
September 17, 2020
The Chabner Pioneers in Oncology Lectureship: Lung Cancer Therapy
Paul Bunn, MD
Medicine-Medical Oncology
James Dudley Chair in Cancer Research
Professor, Lung Cancer
University of Colorado Hospital
September 24, 2020
COVID Response: Lessons Learned from the COVID Surge at MGH and What to Expect for the Future
Kerry Reynolds, MD
Clinical Director, Inpatient Oncology Units
Director, Severe Immunotherapy Complications Program
Massachusetts General Hospital Cancer Center
Paul Biddinger, MD
Chief, Division of Emergency Preparedness
Director, MGH Center for Disaster Medicine
Anne Prestipino, MPH
Senior Vice President of Strategy and Clinical Operations
Massachusetts General Hospital Cancer Center
October 1, 2020
COVID Response: Using Registries to Inform Risk Assessment and Care Delivery for Individuals with Cancer During the COVID-19 Pandemic
William Wood, MD
Associate Professor of Medicine, Division of Hematology
UNC School of Medicine
October 8, 2020
COVID Response: Temporal and Spatial Heterogeneity of SARS-CoV-2 Pulmonary Infection
David Ting, MD
Assistant Physician, Hematology/Oncology
Massachusetts General Hospital Cancer Center
October 15, 2020
21st-Century Impact of Cancer Care
Robert Winn, MD
Director
Senior Associate Dean for Cancer Innovation
VCU School of Medicine
October 22, 2020
Me Biased? Unconscious Bias in Medicine and Medical Education
Narjust Duma, MD
Hematology/Oncology Faculty
Department of Medicine
School of Medicine and Public Health
University of Wisconsin
October 29, 2020
Clinical Pathologic Conference: 34-Year-Old Woman with Abdominal Distension, Fatigue, and Acute Kidney Insufficiency
Sundar Jagannath, MD
Mount Sinai Hospital, NYC
Mark Anderson, MD
Department of Radiology
Massachusetts General Hospital
Andrew Yee, MD
Massachusetts General Hospital Cancer Center
Robert Hasserjian, MD
Department of Pathology
Massachusetts General Hospital
November 5, 2020
How Many Myelomas Are There?
Nikhil Munshi, MD
Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
November 12, 2020
Heparin-Induced Thrombocytopenia: Still with us. Still a problem.
Douglas Cines, MD
Professor of Medicine, Professor of Pathology and Laboratory Medicine
University of Pennsylvania Perelman School of Medicine
Director, Coagulation Laboratory
November 19, 2020
Lippard Lecture
Diego Castrillon, MD
Vernie A. Stembridge, M.D., Distinguished Chair in Pathology
Harold C. Simmons Comprehensive Cancer Center
UT Southwestern Medical Center
December 3, 2020
Chief Fellows Lecture
Chi-Joan How, MD
Medical Oncology Fellow
Dana-Farber Cancer Institute
Connor Johnson, MD
Medical Oncology Fellow
Dana-Farber Cancer Institute
Chris Nabel, MD
Medical Oncology Fellow
Massachusetts General Hospital Cancer Center
December 10, 2020
Debate: Time to De-Escalate Treatment in Oropharyngeal Carcinoma?
Moderator:
Lori Wirth, MD
Medical Director, Center for Head and Neck Cancers
Massachusetts General Hospital Cancer Center
Panelists:
Barbara Burtness, MD
Professor of Medicine
Disease Aligned Research Team Leader, Head and Neck Cancers Program
Co-Leader, Developmental Therapeutics
Yale Cancer Center
Annie Chan, MD
Director, Head and Neck Radiation Oncology Research Program
Massachusetts General Hospital
John Clark, MD
Clinical Director, Center for Head and Neck Cancers
Massachusetts General Hospital Cancer Center
Jeremy Richmon, MD
Director, Head and Neck Robotic Surgery
Massachusetts Eye and Ear
Education & Training at the Cancer Center
A world leader in cancer research & comprehensive cancer treatment, we are dedicated to educating the next generation of cancer specialists.
Center for Cancer Research
The scientific engine for discovery for the Mass General Cancer Center.
Grand Rounds
Mass General Cancer Center Grand Rounds is a CME accredited weekly seminar series. Cutting edge topics, case studies and conference highlights will be presented.